Clear Street’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Clear Street’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,518	Closed	-$180K	–	1579
2023 Q1	$180K	Buy	17,518 +17,468	+34,936%	+$179K	0.01%	138
2022 Q4	$1K	Sell	50 -70	-58%	-$711	﹤0.01%	1010
2022 Q3	$1K	Buy	+120	New	+$1.21K	﹤0.01%	1121
2022 Q1	–	Sell	-1,933	Closed	-$19K	–	572
2021 Q4	$19K	Buy	+1,933	New	+$19.1K	﹤0.01%	165

Clear Street's IQMD Position: Q2 2023 in Review

Clear Street sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q2 2023, closing a stake of 17,518 shares — an estimated $180K sold.

Clear Street first reported a position in IQMD in Q4 2021 and held it in 4 quarters. The position peaked at $180K in Q1 2023. 0 funds tracked by Wall St. Rank hold IQMD as of Q2 2023.

Clear Street reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Clear Street sold 17,518 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $180K.
Clear Street first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 4 quarters.
Clear Street's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $180K in Q1 2023.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Clear Street's 13F filing for Q2 2023, filed 14 Aug 2023.